Literature DB >> 2481407

Potent cholecystokinin antagonist L 364718 stimulates food intake in rats.

R D Reidelberger1, M F O'Rourke.   

Abstract

The cholecystokinin (CCK) receptor antagonist L 364718 was used to examine the role of CCK in control of food intake. Effects of L 364718 (0.01-1 mg/kg ip) on the feeding response to a maximal inhibitory dose of cholecystokinin COOH-terminal octapeptide (CCK-8; 8 nmol/kg ip) and on food intake alone were determined in rats fed ad libitum during the dark cycle. CCK-8 suppressed feeding by 48%. L 364718 reversed this effect dose dependently; the minimal effective dose was 0.03 mg/kg, and complete reversal occurred at 0.1 and 0.3 mg/kg. L 364718 (0.03 mg/kg) caused a parallel, rightward shift in the dose-response curve to CCK-8 [1-128 nmol/kg, half-maximal effective dose (ED50) increased 16-fold] but did not alter the maximal response, consistent with competitive-like kinetics. L 364718 stimulated liquid and solid food intake dose-dependently by 11-35%. The minimal effective dose was 0.1 mg/kg; maximal stimulation occurred at 0.3 mg/kg. Duodenal infusion of bile-pancreatic juice did not alter the response. These results support an important role for CCK in control of food intake.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2481407     DOI: 10.1152/ajpregu.1989.257.6.R1512

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  20 in total

1.  Obesity and gastrointestinal sensory-motor function.

Authors:  G Anton Decker; Michael D Crowell
Journal:  Curr Treat Options Gastroenterol       Date:  2005-08

Review 2.  Gastrointestinal regulation of food intake.

Authors:  David E Cummings; Joost Overduin
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

Review 3.  Central control of body weight and appetite.

Authors:  Stephen C Woods; David A D'Alessio
Journal:  J Clin Endocrinol Metab       Date:  2008-11       Impact factor: 5.958

Review 4.  Hyperphagia and obesity in OLETF rats lacking CCK-1 receptors.

Authors:  Timothy H Moran; Sheng Bi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

5.  Sensitivity of vagal mucosal afferents to cholecystokinin and its role in afferent signal transduction in the rat.

Authors:  W Richards; K Hillsley; C Eastwood; D Grundy
Journal:  J Physiol       Date:  1996-12-01       Impact factor: 5.182

6.  Role of capsaicin-sensitive peripheral sensory neurons in anorexic responses to intravenous infusions of cholecystokinin, peptide YY-(3-36), and glucagon-like peptide-1 in rats.

Authors:  Roger Reidelberger; Alvin Haver; Krista Anders; Bettye Apenteng
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-08-12       Impact factor: 4.310

7.  Time-course of the pancreatic changes following long-term stimulation or inhibition of the CCK-A receptor.

Authors:  B Ohlsson; J Axelson; B Sternby; J F Rehfeld; I Ihse
Journal:  Int J Pancreatol       Date:  1995-08

Review 8.  Inconsistencies in the assessment of food intake.

Authors:  Stephen C Woods; Wolfgang Langhans
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-10-16       Impact factor: 4.310

9.  Effect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide.

Authors:  R J Lieverse; J B Jansen; A A Masclee; L C Rovati; C B Lamers
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

10.  CCK(1) receptor is essential for normal meal patterning in mice fed high fat diet.

Authors:  Michael J Donovan; Gabriel Paulino; Helen E Raybould
Journal:  Physiol Behav       Date:  2007-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.